Pharma channel feed – Endpoints News

Pharma channel feed

Novo turns to Septerna for oral obesity medicines in deal worth up to $2.2B

Last month

HHS focuses on 'transparency' in third-round IRA negotiation guidance

Last month

Some generics, biosimilar drugmakers say they can withstand tariff impact

Last month

Watch Post-Hoc Live: Trump's 'most favored nation' plan to cut drug prices

Last month

Bayer starts 2025 by cutting 2,000 jobs as it homes in on year-end rehaul target

Last month

Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks rise

Last month

Lack of detail in Trump's drug price plan raises more questions than answers

Last month

PBM overhaul and drug price negotiations make the cut in Republicans' tax bill

Last month

Roche could rethink $50B US expansion plan if new policies 'harm' operations

Last month

Updated: White House threatens ‘most favored nation’ plan to lower US drug prices, but many questions remain

Last month

Trump says he'll sign order on 'most favored nation' drug price plans Monday

Last month

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi

2 months ago

Lonza says its US-based sites are in high demand as pharma tariffs near

2 months ago

Illumina confirms SEC has closed investigation into $8B Grail deal

2 months ago

Takeda announces handful of pipeline cuts in effort to ‘pivot resources’

2 months ago

Illumina forecasts $85M in tariff costs, decrease in China sales

2 months ago

AstraZeneca loses appeals court fight over IRA drug price negotiations

2 months ago

GSK awaits Nucala decision after FDA target date passes

2 months ago

FDA grants Verastem first approval for rare ovarian cancer treatment

2 months ago

FDA will convene vaccine advisors to discuss Covid strain updates

2 months ago

Gilead reveals plans to put another $11B into US manufacturing

2 months ago

Teva plans staff cuts as it commits to accelerating growth

2 months ago

PhRMA says tariffs are 'not the answer' as industry trade probe closes for comments

2 months ago

FDA's ODAC will review drugs for four different cancers at meeting in May

2 months ago

First page Previous page 5 6 789 10 11 Next page Last page